Letter to our shareholders - April 2020

Here is our April 2020 issue which details the new organization of the Group into 3 Business Units. Interviews and articles on the menu.
Anatomy of the new face of Oncodesign: BU Service, BU Biotech & BU Artificial Intelligence.

Without forgetting the editorial by Ph. Genne entitled "how much is a human life worth".
"Behind any disaster, there is the promise of reconstruction and it is in this direction that we must look ..." - Philippe GENNE, President and CEO of Oncodesign

Letter to Shareholders April 2020 cover

DOWNLOAD OUR LETTER

Letter to our shareholders - June 2019

"The health sector is in great need of innovations, & will continue to be for a long time yet" says Philippe Genne, CEO & founder, Oncodesign Biotechnology.

lettertoshareholders June19

DOWNLOAD OUR LETTER

Letter to our shareholders - November 2018

"I urge you all to stay aboard and keep your eyes firmly fixed on the future:  we believe in it" says Philippe Genne, CEO & founder, Oncodesign Biotechnology.

lts nov18

DOWNLOAD OUR LETTER

Letter to our shareholders - June 2018

"Step by step, we are building our future with innovation" says Philippe Genne, CEO & founder, Oncodesign Biotechnology.

Letter to our shareholders - June 2018

DOWNLOAD OUR LETTER